Literature DB >> 12087174

DNA bending and unwinding due to the major 1,2-GG intrastrand cross-link formed by antitumor cis-diamminedichloroplatinum(II) are flanking-base independent.

Kristyna Stehlikova1, Hana Kostrhunova, Jana Kasparkova, Viktor Brabec.   

Abstract

Antitumor cisplatin [cis-diamminedichloroplatinum(II)] forms on DNA predominantly intrastrand cross-links between neighboring purine residues. Several discoveries suggested that the toxicity of cisplatin originated from these lesions. The formation of 1,2-GG intrastrand cross-link of cisplatin leads to marked conformational alterations in DNA including a directional, rigid bend toward the major groove and local unwinding. These altered structures attract various cellular proteins. This phenomenon has been postulated to mediate antitumor properties of cisplatin. Importantly, the binding affinity of several proteins that specifically recognize 1,2-GG intrastrand cross-link to platinated DNA is modulated by the nature of the base pairs that immediately flank the platinated d(GpG) site. However, the influence of sequence context on DNA bending and unwinding due to the formation of the 1,2-GG intrastrand cross-link has not been extensively investigated. In the present study we have employed electrophoretic retardation (phasing) assay to analyze bending and unwinding induced by the single, site-specific 1,2-GG intrastrand cross-link immediately flanked by various bases formed by cisplatin in nine oligodeoxyribonucleotide duplexes. The results indicate that bending and unwinding of DNA as a consequence of the formation of the major adduct of cisplatin is, in the first approximation, independent of the base pairs flanking the platinated d(GpG) site.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12087174      PMCID: PMC117060          DOI: 10.1093/nar/gkf405

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  39 in total

Review 1.  DNA bending induced by covalently bound drugs. Gel electrophoresis and chemical probe studies.

Authors:  M Leng
Journal:  Biophys Chem       Date:  1990-04       Impact factor: 2.352

Review 2.  Recognition of cisplatin adducts by cellular proteins.

Authors:  M Kartalou; J M Essigmann
Journal:  Mutat Res       Date:  2001-07-01       Impact factor: 2.433

3.  Bending studies of DNA site-specifically modified by cisplatin, trans-diamminedichloroplatinum(II) and cis-[Pt(NH3)2(N3-cytosine)Cl]+.

Authors:  S F Bellon; S J Lippard
Journal:  Biophys Chem       Date:  1990-04       Impact factor: 2.352

4.  Basis for recognition of cisplatin-modified DNA by high-mobility-group proteins.

Authors:  U M Ohndorf; M A Rould; Q He; C O Pabo; S J Lippard
Journal:  Nature       Date:  1999-06-17       Impact factor: 49.962

5.  Cisplatin- and UV-damaged DNA lure the basal transcription factor TFIID/TBP.

Authors:  P Vichi; F Coin; J P Renaud; W Vermeulen; J H Hoeijmakers; D Moras; J M Egly
Journal:  EMBO J       Date:  1997-12-15       Impact factor: 11.598

6.  Site-specific d(GpG) intrastrand cross-links formed by dinuclear platinum complexes. Bending and NMR studies.

Authors:  J Kaspárková; K J Mellish; Y Qu; V Brabec; N Farrell
Journal:  Biochemistry       Date:  1996-12-24       Impact factor: 3.162

7.  Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex.

Authors:  N Poklar; D S Pilch; S J Lippard; E A Redding; S U Dunham; K J Breslauer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

8.  Solution structure of a cisplatin-induced DNA interstrand cross-link.

Authors:  H Huang; L Zhu; B R Reid; G P Drobny; P B Hopkins
Journal:  Science       Date:  1995-12-15       Impact factor: 47.728

9.  Sequence-dependent distortions induced in DNA by monofunctional platinum(II) binding.

Authors:  V Brabec; J Reedijk; M Leng
Journal:  Biochemistry       Date:  1992-12-15       Impact factor: 3.162

10.  TATA binding protein discriminates between different lesions on DNA, resulting in a transcription decrease.

Authors:  F Coin; P Frit; B Viollet; B Salles; J M Egly
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

View more
  7 in total

1.  Conformation of DNA GG intrastrand cross-link of antitumor oxaliplatin and its enantiomeric analog.

Authors:  Jaroslav Malina; Olga Novakova; Marie Vojtiskova; Giovanni Natile; Viktor Brabec
Journal:  Biophys J       Date:  2007-08-17       Impact factor: 4.033

2.  Chiral differentiation of DNA adducts formed by enantiomeric analogues of antitumor cisplatin is sequence-dependent.

Authors:  Olivier Delalande; Jaroslav Malina; Viktor Brabec; Jirí Kozelka
Journal:  Biophys J       Date:  2005-04-01       Impact factor: 4.033

3.  Multiscale modeling of double-helical DNA and RNA: a unification through Lie groups.

Authors:  Kevin C Wolfe; Whitney A Hastings; Samrat Dutta; Andrew Long; Bruce A Shapiro; Thomas B Woolf; Martin Guthold; Gregory S Chirikjian
Journal:  J Phys Chem B       Date:  2012-06-07       Impact factor: 2.991

4.  DNA-protein cross-linking by trans-[PtCl(2)(E-iminoether)(2)]. A concept for activation of the trans geometry in platinum antitumor complexes.

Authors:  Olga Novakova; Jana Kasparkova; Jaroslav Malina; Giovanni Natile; Viktor Brabec
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

5.  Analysis of single, cisplatin-induced DNA bends by atomic force microscopy and simulations.

Authors:  Samrat Dutta; Claudio Rivetti; Natalie R Gassman; Carl G Young; Bradley T Jones; Karin Scarpinato; Martin Guthold
Journal:  J Mol Recognit       Date:  2018-06-03       Impact factor: 2.137

6.  Cisplatin induces loop structures and condensation of single DNA molecules.

Authors:  Xi-Miao Hou; Xing-Hua Zhang; Kong-Ji Wei; Chao Ji; Shuo-Xing Dou; Wei-Chi Wang; Ming Li; Peng-Ye Wang
Journal:  Nucleic Acids Res       Date:  2009-01-07       Impact factor: 16.971

7.  Translesion activity of PrimPol on DNA with cisplatin and DNA-protein cross-links.

Authors:  Elizaveta O Boldinova; Anna V Yudkina; Evgeniy S Shilkin; Diana I Gagarinskaya; Andrey G Baranovskiy; Tahir H Tahirov; Dmitry O Zharkov; Alena V Makarova
Journal:  Sci Rep       Date:  2021-09-02       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.